University of Oklahoma: Study Advances Understanding of Metformin Effects on Fetus, Including Future Risks of Obesity and Diabetes
November 13, 2024
November 13, 2024
NORMAN, Oklahoma, Nov. 13 (TNSres) -- The University of Oklahoma issued the following news release:
A study published in the American Journal of Obstetrics and Gynecology demonstrates that when the diabetes drug metformin is given to the mother during pregnancy, fetus growth is restricted, including a slowed maturing of the kidneys, which has been linked to a higher risk of obesity and insulin resistance in childhood.
Metformin, which is prescribed to 50 million America . . .
A study published in the American Journal of Obstetrics and Gynecology demonstrates that when the diabetes drug metformin is given to the mother during pregnancy, fetus growth is restricted, including a slowed maturing of the kidneys, which has been linked to a higher risk of obesity and insulin resistance in childhood.
Metformin, which is prescribed to 50 million America . . .